Bill Text: IL SB3239 | 2023-2024 | 103rd General Assembly | Enrolled
NOTE: There are more recent revisions of this legislation. Read Latest Draft
Bill Title: Amends the Illinois Health and Hazardous Substances Registry Act. Repeals provisions relating to the Health and Hazardous Substances Coordinating Council.
Spectrum: Partisan Bill (Democrat 3-0)
Status: (Passed) 2024-08-09 - Public Act . . . . . . . . . 103-0962 [SB3239 Detail]
Download: Illinois-2023-SB3239-Enrolled.html
Bill Title: Amends the Illinois Health and Hazardous Substances Registry Act. Repeals provisions relating to the Health and Hazardous Substances Coordinating Council.
Spectrum: Partisan Bill (Democrat 3-0)
Status: (Passed) 2024-08-09 - Public Act . . . . . . . . . 103-0962 [SB3239 Detail]
Download: Illinois-2023-SB3239-Enrolled.html
| |||||||
| |||||||
1 | AN ACT concerning health.
| ||||||
2 | Be it enacted by the People of the State of Illinois, | ||||||
3 | represented in the General Assembly:
| ||||||
4 | Section 5. The Illinois Health and Hazardous Substances | ||||||
5 | Registry Act is amended by changing Sections 3, 4, 6, 9, and 13 | ||||||
6 | as follows:
| ||||||
7 | (410 ILCS 525/3) (from Ch. 111 1/2, par. 6703) | ||||||
8 | Sec. 3. For the purposes of this Act, unless the context | ||||||
9 | requires otherwise: | ||||||
10 | (a) "Department" means the Illinois Department of Public | ||||||
11 | Health. | ||||||
12 | (b) "Director" means the Director of the Illinois | ||||||
13 | Department of Public Health. | ||||||
14 | (c) (Blank). "Council" means the Health and Hazardous | ||||||
15 | Substances Coordinating Council created by this Act. | ||||||
16 | (d) "Registry" means the Illinois Health and Hazardous | ||||||
17 | Substances Registry established by the Department of Public | ||||||
18 | Health under Section 6 of this Act. | ||||||
19 | (e) "Cancer" means all malignant neoplasms, regardless of | ||||||
20 | the tissue of origin, including malignant lymphoma and | ||||||
21 | leukemia. | ||||||
22 | (f) "Cancer incidence" means a medical diagnosis of | ||||||
23 | cancer, consisting of a record of cases of cancer and |
| |||||||
| |||||||
1 | specified cases of tumorous or precancerous diseases which | ||||||
2 | occur in Illinois, and such other information concerning these | ||||||
3 | cases as the Department deems necessary or appropriate in | ||||||
4 | order to conduct thorough and complete epidemiological surveys | ||||||
5 | of cancer and cancer-related diseases in Illinois. | ||||||
6 | (g) "Occupational disease" includes but is not limited to | ||||||
7 | all occupational diseases covered by the Workers' Occupational | ||||||
8 | Diseases Act. | ||||||
9 | (h) "Hazardous substances" means a hazardous substance as | ||||||
10 | defined in the Environmental Protection Act. | ||||||
11 | (i) "Hazardous substances incident" includes but is not | ||||||
12 | limited to a spill, fire, or accident involving hazardous | ||||||
13 | substances, illegal disposal, transportation, or use of | ||||||
14 | hazardous substances, and complaints or permit violations | ||||||
15 | involving hazardous substances. | ||||||
16 | (j) "Company profile" includes but is not limited to the | ||||||
17 | name of any company operating in the State of Illinois which | ||||||
18 | generates, uses, disposes of or transports hazardous | ||||||
19 | substances, identification of the types of permits issued in | ||||||
20 | such company's name relating to transactions involving | ||||||
21 | hazardous substances, inventory of hazardous substances | ||||||
22 | handled by such company, and the manner in which such | ||||||
23 | hazardous substances are used, disposed of, or transported by | ||||||
24 | the company. | ||||||
25 | (k) "Hazardous nuclear material" means (1) any source or | ||||||
26 | special nuclear material intended for use or used as an energy |
| |||||||
| |||||||
1 | source in a production or utilization facility as defined in | ||||||
2 | Sec. 11.v. or 11.cc. of the federal Atomic Energy Act of 1954 | ||||||
3 | as amended; (2) any fuel which has been discharged from such a | ||||||
4 | facility following irradiation, the constituent elements of | ||||||
5 | which have not been separated by reprocessing; or (3) any | ||||||
6 | by-product material resulting from operation of such a | ||||||
7 | facility. | ||||||
8 | (l) "Adverse pregnancy outcome" includes but is not | ||||||
9 | limited to birth defects, fetal loss, infant mortality, low | ||||||
10 | birth weight, selected life-threatening conditions, and other | ||||||
11 | developmental disabilities as defined by the Department. | ||||||
12 | (m) "News medium" means any newspaper or other periodical | ||||||
13 | issued at regular intervals, whether in print or electronic | ||||||
14 | format, and having a general circulation; a news service, | ||||||
15 | whether in print or electronic format; a radio station, a | ||||||
16 | television station; a television network; a community antenna | ||||||
17 | television service; and any person or corporation engaged in | ||||||
18 | the making of news reels or other motion picture news for | ||||||
19 | public showing. | ||||||
20 | (n) "Researcher" means an individual who is affiliated | ||||||
21 | with or supported by universities, academic centers, research | ||||||
22 | institutions, hospitals, and governmental entities who conduct | ||||||
23 | scientific research or investigation on human diseases. | ||||||
24 | (Source: P.A. 95-941, eff. 8-29-08.)
| ||||||
25 | (410 ILCS 525/4) (from Ch. 111 1/2, par. 6704) |
| |||||||
| |||||||
1 | Sec. 4. (a) There is created the Health and Hazardous | ||||||
2 | Substances Coordinating Council, to be comprised of the | ||||||
3 | following persons ex officio or their designees: Dean of the | ||||||
4 | School of Public Health of the University of Illinois, | ||||||
5 | Director of Natural Resources, Director of Public Health, | ||||||
6 | Director of Labor, Director of Agriculture, Director of the | ||||||
7 | Environmental Protection Agency and the Director of Nuclear | ||||||
8 | Safety. | ||||||
9 | The University of Illinois School of Public Health shall | ||||||
10 | advise the Department in the design, function and utilization | ||||||
11 | of the Registry. | ||||||
12 | (b) To facilitate the collection of cancer incidence | ||||||
13 | information, the Department, in consultation with the Advisory | ||||||
14 | Board of Cancer Control, shall have the authority to require | ||||||
15 | hospitals, laboratories or other facilities to report | ||||||
16 | incidences of cancer and other specified tumorous and | ||||||
17 | precancerous diseases to the Department, and to require the | ||||||
18 | submission of such other information pertaining to or in | ||||||
19 | connection with such reported cases as the Department deems | ||||||
20 | necessary or appropriate for the purposes of this Act. The | ||||||
21 | Department may promulgate rules or regulations specifying the | ||||||
22 | hospitals, laboratories or other facilities which are required | ||||||
23 | to submit information pursuant to this Section, the types of | ||||||
24 | information required to be submitted, methods of submitting | ||||||
25 | such information and any other detail deemed by the Department | ||||||
26 | to be necessary or appropriate for administration of this Act. |
| |||||||
| |||||||
1 | Nothing in this Act shall be construed to compel any | ||||||
2 | individual to submit to a medical examination or supervision. | ||||||
3 | (c) The Director shall by rule or regulation establish | ||||||
4 | standards or guidelines for ensuring the protection of | ||||||
5 | information made confidential or privileged under law. | ||||||
6 | (d) The identity, or any group of facts that tends to lead | ||||||
7 | to the identity, of any person whose condition or treatment is | ||||||
8 | submitted to the Illinois Health and Hazardous Substances | ||||||
9 | Registry is confidential and shall not be open to public | ||||||
10 | inspection or dissemination and is exempt from disclosure | ||||||
11 | under Section 7 of the Freedom of Information Act. The | ||||||
12 | following data elements, alone or in combination, are | ||||||
13 | confidential, shall not be open to public inspection or | ||||||
14 | dissemination, and are exempt from disclosure under Section 7 | ||||||
15 | of the Freedom of Information Act: name, social security | ||||||
16 | number, street address, email address, telephone number, fax | ||||||
17 | number, medical record number, certificate/license number, | ||||||
18 | reporting source (unless permitted by the reporting facility), | ||||||
19 | age (unless aggregated for 5 or more years, ZIP code (unless | ||||||
20 | aggregated for 5 or more years), and diagnosis date (unless | ||||||
21 | aggregated for one or more years for the entire State or for 3 | ||||||
22 | or more years for a single county). The identity of any person | ||||||
23 | or persons claimed to be derived from cancer registry data is | ||||||
24 | not admissible in evidence, and no court shall require | ||||||
25 | information to be produced in discovery if it determines that | ||||||
26 | the information tends to lead to the identity of any person. |
| |||||||
| |||||||
1 | Information for specific research purposes may be released in | ||||||
2 | accordance with procedures established by the Department. | ||||||
3 | Except as provided by rule, and as part of an epidemiologic | ||||||
4 | investigation, an officer or employee of the Department may | ||||||
5 | interview a patient named in a report made under this Act, or | ||||||
6 | relatives of any such patient, only with the express written | ||||||
7 | consent of the patient. | ||||||
8 | (e) Hospitals, laboratories, other facilities or | ||||||
9 | physicians shall not be held liable for the release of | ||||||
10 | information or confidential data to the Department in | ||||||
11 | accordance with this Act. The Department shall protect any | ||||||
12 | information made confidential or privileged under law. | ||||||
13 | (Source: P.A. 95-941, eff. 8-29-08.)
| ||||||
14 | (410 ILCS 525/6) (from Ch. 111 1/2, par. 6706) | ||||||
15 | Sec. 6. (a) No later than January 1, 1985, the Department | ||||||
16 | shall commence the work necessary to compile the information | ||||||
17 | which will constitute the Health and Hazardous Substances | ||||||
18 | Registry. The Registry shall consist of the compilation of | ||||||
19 | information in the following categories: | ||||||
20 | (i) adverse pregnancy outcomes; | ||||||
21 | (ii) cancer incidences; | ||||||
22 | (iii) occupational diseases; | ||||||
23 | (iv) location, transportation, and exposure to hazardous | ||||||
24 | nuclear materials; | ||||||
25 | (v) company profiles; and |
| |||||||
| |||||||
1 | (vi) hazardous substances incidents. | ||||||
2 | The Department , pursuant to any guidelines established by | ||||||
3 | the Council, shall promulgate rules or regulations specifying | ||||||
4 | the types of information in each category which will be | ||||||
5 | compiled for the Registry. Such information shall be compiled | ||||||
6 | in the Registry in such a manner as to allow for geographical | ||||||
7 | correlation of the data on public health and the data on | ||||||
8 | hazardous substances and hazardous nuclear materials. To the | ||||||
9 | extent feasible, the Registry shall be compatible with other | ||||||
10 | national models of such type so as to facilitate the | ||||||
11 | coordination of information with other data bases. | ||||||
12 | (Source: P.A. 83-1361.)
| ||||||
13 | (410 ILCS 525/9) (from Ch. 111 1/2, par. 6709) | ||||||
14 | Sec. 9. The Department shall utilize the Registry to | ||||||
15 | conduct research on the relationships between hazardous | ||||||
16 | substances, hazardous nuclear materials, and public health | ||||||
17 | issues. The In consultation with the Council, the Director | ||||||
18 | shall establish guidelines for determining the specific | ||||||
19 | questions and areas to be researched. The guidelines shall | ||||||
20 | specifically include the question of the potential public | ||||||
21 | health significance of an increase in cancer incidence. The | ||||||
22 | Upon the approval of the Council, the information contained in | ||||||
23 | the Registry shall be available to other State agencies | ||||||
24 | wishing to conduct research on these issues. Upon review and | ||||||
25 | approval of an appropriate Institutional Review Board (IRB) or |
| |||||||
| |||||||
1 | its equivalent on protection of human subjects in research, | ||||||
2 | the Department shall release data to researchers for purposes | ||||||
3 | of medical and scientific research consistent with the | ||||||
4 | fundamental purposes of the Registry. | ||||||
5 | (Source: P.A. 95-941, eff. 8-29-08.)
| ||||||
6 | (410 ILCS 525/13) (from Ch. 111 1/2, par. 6713) | ||||||
7 | Sec. 13. (a) Violation of this Act is a Class A | ||||||
8 | misdemeanor. | ||||||
9 | (b) Any person who violates this Act shall be liable for a | ||||||
10 | civil penalty not to exceed $1,000 for each violation. | ||||||
11 | (c) The Department Council may request the Attorney | ||||||
12 | General or the State's Attorney of the county in which the | ||||||
13 | violation occurred to proceed in a court of competent | ||||||
14 | jurisdiction to secure such relief as provided in this | ||||||
15 | Section, as well as injunctive relief to restrain violations | ||||||
16 | of this Act. | ||||||
17 | (Source: P.A. 83-1361.)
|